Literature DB >> 23208527

A novel technique of otic barotrauma management using modified intravenous cannulae.

Qi Zhang1, Catherine Banks, Sim Choroomi, Thomas Kertesz.   

Abstract

This article provides the first detailed description and systematic evaluation of the management of otic barotrauma using modified intravenous cannulae. A 24-gauge IC cannula was modified as a tool for tympanostomy tube placement and middle ear ventilation. The medical records of 271 ears of 156 adult patients (median age 49 years) who underwent this procedure were reviewed retrospectively. Hundred and ninty-one tubes were placed for otalgia because of hyperbaric oxygen therapy, 58 tubes were inserted for air travel prophylaxis and 22 tubes were placed for management of otic barotrauma post-flight. All the patients who had this procedure for prophylaxis experienced regular otic barotrauma symptoms during air travel prior to tube placement. All patients were reviewed 6 weeks (range 2-9 weeks) post-procedure. This technique of otic barotrauma management worked effectively in 99 % of treated patients. On follow-up, 88 % of tubes were found to be extruded and non-extruded tubes were removed in clinic without any anaesthesia. 99.6 % of tympanic membrane had healed completely and spontaneously without sequelae. Given the safety, effectiveness, low risk of complications associated with this novel tympanostomy technique, it provided a simple yet effective therapeutic option for the management of otic barotrauma. Finally, this technique can be easily applied in all health settings as it only requires medical supplies readily available in hospitals, therefore there is no additional cost.

Entities:  

Mesh:

Year:  2012        PMID: 23208527     DOI: 10.1007/s00405-012-2301-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

1.  Sex distribution in children with tympanosclerosis after insertion of a tympanostomy tube.

Authors:  A Koc; C Uneri
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-01       Impact factor: 2.503

2.  Tuberculous otitis media developing as a complication of tympanostomy tube insertion.

Authors:  Chang Woo Kim; Jae Won Jin; Young-Soo Rho
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-21       Impact factor: 2.503

3.  Myringosclerosis after tympanostomy tube insertion: relation with tube retention time and gender.

Authors:  Huseyin Yaman; Ender Guclu; Suleyman Yilmaz; Ozcan Ozturk
Journal:  Auris Nasus Larynx       Date:  2010-04-14       Impact factor: 1.863

4.  Shepard grommet tympanostomy tube complications in children with chronic otitis media with effusion.

Authors:  Huseyin Yaman; Suleyman Yilmaz; Nihal Alkan; Bugra Subasi; Ender Guclu; Ozcan Ozturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-05       Impact factor: 2.503

Review 5.  Otic barotrauma from air travel.

Authors:  S Mirza; H Richardson
Journal:  J Laryngol Otol       Date:  2005-05       Impact factor: 1.469

6.  Short-term tympanostomy in conjunction with hyperbaric oxygen therapy.

Authors:  J T Vrabec; K S Clements; J T Mader
Journal:  Laryngoscope       Date:  1998-08       Impact factor: 3.325

7.  Long-term results of Armstrong beveled grommet tympanostomy tubes in children.

Authors:  D Richard Lindstrom; Brian Reuben; Ken Jacobson; Valerie A Flanary; Joseph E Kerschner
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

8.  Failed tube extrusion is not a random event in children or their siblings.

Authors:  Roya Azadarmaki; John P Gaughan; Glenn Isaacson
Journal:  Laryngoscope       Date:  2008-07       Impact factor: 3.325

9.  Factors of the blockage of ventilation tubes in the immediate postoperative period.

Authors:  Eun-ju Jeon; Yong-Soo Park; Seung-Kyun Lee; Ki-Hong Chang; So-Young Park; Kyoung-Ho Park; Dong-Hee Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-27       Impact factor: 2.503

10.  Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss.

Authors:  Takeyuki Fujimura; Hideaki Suzuki; Teruo Shiomori; Tsuyoshi Udaka; Takanori Mori
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-06       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.